Share this event on:
  • LinkedIn

Recomend this page

Thank you, we sent your recommendation to the desired recipient.

Sorry, this functionality is not available right now.
Please try with this link. Thank you.

Pediatric Leukemia Research Grant - IEO-CCM Foundation € 25,000

Pediatric Leukemia Research Grant - IEO-CCM Foundation € 25,000

The UniCredit Foundation supports the Acute Lymphoblastic Leukemia Scholarship, which focuses on the leading cause of cancer-related death in children and young adults




In 2020, the UniCredit Foundation continued its commitment to support pediatric scientific research though a research grant offered in partnership with the IEO-CCM (European Institute of Oncology Foundation and the Monzino Foundation Cardiology Center). The research grant is intended for researchers studying acute lymphoblastic leukemia (ALL), which is the most common pediatric tumor, with the highest incidence rates in patients between 2 and 5 years old.

This illness is the leading cause of cancer-related death in children and young adults. Relapses occur in 20% of patients, even 10-20 years after treatment. ALL is characterized by the presence of multiple tumor clones, which change and evolve over time. The annual research grant was awarded to researcher Iman Nazari, who will participate in the "Lo IEO contro le Leucemie Infantili" (IEO against childhood leukemias) project at the Department of Experimental Oncology at the European Institute of
Oncology. The goal of the project is to define how clone cells evolve throughout the disease, from its onset to relapse, and analyze the stages of the disease to define if there are clone cells present at its onset and how they are selected and changed by chemotherapy.

The Partner - The IEO-CCM Foundation

The IEO-CCM Foundation is a not-for-profit organisation that funds clinical and experimental research and assistance oncology and cardiology patients of European
Institute of Oncology and Centro Cardiologico Monzino, with the aim of identifying the better treatments for patients and to support new innovative projects. Research funding is strategic for the work of the doctors and researchers working at IEO and Monzino, because the progress and results achieved in the laboratory can be
quickly transformed into more personalised treatments and more effective diagnostics available to patients. Therefore, the goal priority of the IEO-CCM Foundation and the Institutes is to further strengthen the fundraising in order to find more and more resources available to support the excellent research carried out by IEO and Monzino
and allow them to work with continuity in the medium/long term